Company intelligence / Profile preview

Arab Drug Company

Ownership: Private
Development stage: Commercial

Overview

ADCO is a leading Egyptian pharmaceutical manufacturer with over 130 products across 40 drug groups. It is recognized as a pioneer in aerosol manufacturing (both inhaler and topical), operates under strict GMP regulations, and holds ISO 9001 and ISO14001 certifications. The company has modern production facilities and continues to expand its capabilities.

Modalities: Small moleculeBiologicAerosol-based drugs
Industry: Biotech

Drug pipeline

2 assets

Antox

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on Arab Drug Company.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Arab Drug Company.

Explore the full profile